title: Regulation of TNFα converting enzyme activity in visceral adipose tissue of obese mice.
abstract: Tumor necrosis factor α (TNFα) is a pro-inflammatory cytokine and one of the major mediators of obesity-induced insulin resistance. TNFα is generated through TNFα converting enzyme (TACE)-mediated cleavage of the transmembrane precursor pro-TNFα. Inhibition of TACE resulted in the improvement in glucose and insulin levels in diabetic animals, suggesting a crucial role of TACE activity in glucose metabolism. However, the regulation of TACE activity in insulin-sensitive tissues has not been fully determined. This study aimed to investigate the impact of TACE in insulin-sensitive tissues in the early stage of the development of obesity. C57BL6 mice were fed standard chow (B6-SC) or high-fat/high-sucrose diet (B6-HF/HS). KK-Ay mice were fed SC ad libitum (Ay-AL) or fed reduced amounts of SC (caloric restriction (CR); Ay-CR). As control for Ay-AL, KK mice fed SC ad libitum (KK-AL) were used. TACE activity in visceral adipose tissue (VAT), but not in liver or skeletal muscle, was significantly elevated in B6-HF/HS and Ay-AL compared with B6-SC and KK-AL, respectively. Phosphorylation of JNK and p38MAPK, but not ERK, in VATs from B6-HF/HS and Ay-AL was also significantly elevated. Ay-CR showed significantly lower TACE, JNK and p38MAPK activities in VAT and serum TNFα level compared with those of Ay-AL. In contrast, intraperitoneal injection of TNFα activated TACE, JNK and p38MAPK activities in VAT in KK mice. In conclusion, during the development of obesity, TACE activity is elevated only in VAT, and CR effectively reduced TACE activity and TACE-mediated pro-TNFα shedding in VAT.
authors.affiliation: Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan.
authors.forename: Shuji
authors.initials: S
authors.lastname: Kawasaki
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Motoshima
authors.forename: Satoko
authors.initials: S
authors.lastname: Hanatani
authors.forename: Yuki
authors.initials: Y
authors.lastname: Takaki
authors.forename: Motoyuki
authors.initials: M
authors.lastname: Igata
authors.forename: Atsuyuki
authors.initials: A
authors.lastname: Tsutsumi
authors.forename: Takeshi
authors.initials: T
authors.lastname: Matsumura
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Kondo
authors.forename: Takafumi
authors.initials: T
authors.lastname: Senokuchi
authors.forename: Norio
authors.initials: N
authors.lastname: Ishii
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Kinoshita
authors.forename: Kazuki
authors.initials: K
authors.lastname: Fukuda
authors.forename: Junji
authors.initials: J
authors.lastname: Kawashima
authors.forename: Seiya
authors.initials: S
authors.lastname: Shimoda
authors.forename: Takeshi
authors.initials: T
authors.lastname: Nishikawa
authors.forename: Eiichi
authors.initials: E
authors.lastname: Araki
mesh_terms: D051722:ADAM Proteins / Q000378:metabolism*; D000072198:ADAM17 Protein; D000273:Adipose Tissue / Q000201:enzymology*; D000818:Animals; D031204:Caloric Restriction; D048670:MAP Kinase Kinase 4 / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008820:Mice, Obese; D009765:Obesity / Q000201:enzymology*; D010766:Phosphorylation; D015854:Up-Regulation; D014781:Viscera / Q000201:enzymology; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism
chemical_list: D048051:p38 Mitogen-Activated Protein Kinases; D048670:MAP Kinase Kinase 4; D051722:ADAM Proteins; D000072198:ADAM17 Protein; C000606463:Adam17 protein, mouse